The stock of Innova Captab announced successfully completion of the inspection of its Cephalosporin plant located in Baddi, Himachal Pradesh. The inspection was carried out by the United Kingdom Medicine and Healthcare Products Regulatory Agency (UK-MHRA) from August 18, 2025 to August 20, 2025.
The company said that the inspection ended without any serious or big comment. This information is also available on the company’s website www.innovacaptab.com.
The announcement was made under the Regulations 30 of the Securities and Exchange Board of India (Listing Responsibility and Disclosure Requirements), 2015.
Company Secretary and Compliance Officer Niharika Shukla confirmed the completion of the inspection.
The above information is also available on the company’s website www.innovacaptab.com.